Jaguar Animal Health(DE:1JA2)
€99,225.000.00 (0.00%)
DE:1JA2
Jaguar Animal Health earnings date
€99,225.00
At close:0.00 (0.00%)
Jaguar Animal Health (1JA2) Q2 2022 Earnings Report
0 Followers
DE:1JA2 Q2 2022 EPS Results
- Actual EPS
- -EUR 425,807.25
- Consensus EPS
- -EUR 780,646.63
- Beat/Miss
- Beat by +EUR 354,839.38
- One Year Ago EPS
- -EUR 1,064,518.13
DE:1JA2 Q2 2022 Revenue Results
- Actual Revenue
- EUR 2.63M
- Expected Revenue
- EUR 2.79M
- Beat/Miss
- Missed by -EUR 161.31K
- YoY Revenue Growth
- +658.70%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/22/2022
- Time
- Before Open
- Conference Call
- Monday, August 22, 2022
DE:1JA2 Upcoming Earnings
Jaguar Animal Health's next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1JA2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2026 (Q3) | ―- | -198.08 | ― | ― |
| Aug 19, 2026 | 2026 (Q2) | ―-153.51 | -3511.1 | 95.63% (+3357.59) | |
| May 20, 2026 | 2026 (Q1) | ―- | -526.74 | ― | |
| Apr 07, 2026 | 2025 (Q4) | ―-132.97 | -5714.95 | 97.67% (+5581.98) | |
| Nov 17, 2025 | 2025 (Q3) | ―-2149.09 | -8983.08 | 76.08% (+6833.98) | |
| Aug 14, 2025 | 2025 (Q2) | -2439.98-3511.10 | -34563.47 | 89.84% (+31052.37) | |
| May 15, 2025 | 2025 (Q1) | ―-15.05 | -30799.13 | 99.95% (+30784.08) | |
| Mar 31, 2025 | 2024 (Q4) | -3702.74-5714.95 | -30799.13 | 81.44% (+25084.18) | |
| Nov 13, 2024 | 2024 (Q3) | -20276.09-8983.08 | -195061.16 | 95.39% (+186078.08) | |
| Aug 13, 2024 | 2024 (Q2) | -10302.31-34563.47 | -215593.91 | 83.97% (+181030.44) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
